Avanos recalls Cortrak 2 Enteral Access System devices with Anonymous Account Mode feature. Stop using immediately to confirm tube placement per hospital protocol.
Product labeling is being modified. STOP using the Anonymous Account Mode feature of the CORTRAK 2 device immediately. CONFIRM placement of the NG/NI tube per institution protocol.
Take action
Contact the company
📍Recalling firmAvanos Medical, Inc.5405 Windward Pkwy · Alpharetta, GA 30004-3894
“Avanos Cortrak 2 Enteral Access System: Stop Using Anonymous Account Mode.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/60914-avanos-cortrak-2-enteral-access-system-stop-using-anonymous-account. Based on FDA recall #Z-1032-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1032-2022%22&limit=1).
The FDA announced on March 21, 2022, that Avanos Medical Inc. is recalling the Cortrak 2 Enteral Access System due to labeling issues. The agency advises users to stop using the Anonymous Account Mode feature immediately and confirm tube placement per institutional protocol.
Product Code P20-0950 (Loaner Unit - Halyard version), UDI: 10680651472066
The hazard
The recall addresses product labeling modifications for the device. The FDA stated that users must stop using the Anonymous Account Mode feature immediately and confirm placement of the NG/NI tube per institution protocol.
Context
GovInfoNow's records show Avanos Medical, Inc. has had 18 other recalls on record since October 8, 2019. Recent similar recalls include a PEG Kit with ENFit Connectors recall dated April 30, 2026, and a Ballard Closed Suction Catheters recall dated March 19, 2025.
How to tell if you have this one
Check for the product code 20-0950 or P20-0950 on the device label. The UDI numbers 00350770472010, 00350770472065, 10680651472011, or 10680651472066 indicate recalled units. All serial numbers are affected.
Brand
Avanos
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop Using Anonymous Account Mode
Immediately disable the Anonymous Account Mode feature to prevent incorrect tube placement verification.
Confirm Tube Placement
Verify the NG/NI tube placement according to your institution's protocol before continuing use.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide Distribution. US Nationwide, Australia, Austria, Canada, Germany, Ireland, Kuwait, New Zealand, India, Japan, Malaysia, Netherlands, Panama, Singapore, Switzerland, and United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1032-2022 (March 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1032-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.